Career records & work history
Medicine Doctors
Xian Zhou
Specialties:
Anesthesiology
Xian Living Zhou, Age 472505 Adeline Dr, Burlingame, CA 94010
Xian Zhou Phones & Addresses
2505 Adeline Dr, Burlingame, CA 94010
Pleasanton, CA
3706 Wellington Dr, Pearland, TX 77584 (281) 412-7532
11836 Ampucia Ct, Las Vegas, NV 89138
1012 Stern Ln, San Mateo, CA 94404
904 Peninsula Ave #208, San Mateo, CA 94401
Foster City, CA
Springfield, VA
College Station, TX
Mentions for Xian Living Zhou
Xian Zhou resumes & CV records
Resumes
Xian Zhou
Publications & IP owners
Us Patents
Anti-Angiogenesis Therapy For The Treatment Of Breast Cancer
US Patent:
2010014, Jun 10, 2010
Filed:
Nov 20, 2009
Appl. No.:
12/623297
Inventors:
Gwendolyn Fyfe - San Francisco CA, US
See Chun Phan - Menlo Park CA, US
Xian Zhou - Foster City CA, US
See Chun Phan - Menlo Park CA, US
Xian Zhou - Foster City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 39/395
A61P 35/04
A61P 35/00
A61P 35/04
A61P 35/00
US Classification:
4241331, 4241431
Abstract:
This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human subjects susceptible to or diagnosed with breast cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
Anti-Angiogenesis Therapy For The Treatment Of Breast Cancer
US Patent:
2021009, Apr 1, 2021
Filed:
May 15, 2020
Appl. No.:
16/874936
Inventors:
- South San Francisco CA, US
See Chun Phan - Menlo Park CA, US
Xian Zhou - Foster City CA, US
See Chun Phan - Menlo Park CA, US
Xian Zhou - Foster City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 39/395
A61K 31/337
A61K 31/513
A61K 31/675
A61K 31/704
A61K 45/06
A61K 47/64
A61K 31/00
A61K 31/7068
C07K 16/22
A61K 31/337
A61K 31/513
A61K 31/675
A61K 31/704
A61K 45/06
A61K 47/64
A61K 31/00
A61K 31/7068
C07K 16/22
Abstract:
This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human subjects susceptible to or diagnosed with breast cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
Anti-Angiogenesis Therapy For The Treatment Of Breast Cancer
US Patent:
2017010, Apr 13, 2017
Filed:
Dec 20, 2016
Appl. No.:
15/385602
Inventors:
- South San Francisco CA, US
See Chun Phan - Menlo Park CA, US
Xian Zhou - Foster City CA, US
See Chun Phan - Menlo Park CA, US
Xian Zhou - Foster City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 39/395
A61K 31/337
A61K 31/7068
A61K 31/704
A61K 31/675
C07K 16/22
A61K 31/513
A61K 31/337
A61K 31/7068
A61K 31/704
A61K 31/675
C07K 16/22
A61K 31/513
Abstract:
This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human subjects susceptible to or diagnosed with breast cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
Anti-Angiogenesis Therapy For The Treatment Of Breast Cancer
US Patent:
2016024, Aug 25, 2016
Filed:
May 13, 2016
Appl. No.:
15/154797
Inventors:
- South San Francisco CA, US
See Chun Phan - Menlo Park CA, US
Xian Zhou - Foster City CA, US
See Chun Phan - Menlo Park CA, US
Xian Zhou - Foster City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 39/395
A61K 31/704
A61K 31/513
A61K 45/06
A61K 31/7068
A61K 31/704
A61K 31/513
A61K 45/06
A61K 31/7068
Abstract:
This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human subjects susceptible to or diagnosed with breast cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
Anti-Angiogenesis Therapy For The Treatment Of Breast Cancer
US Patent:
2015024, Sep 3, 2015
Filed:
May 15, 2015
Appl. No.:
14/714177
Inventors:
- South San Francisco CA, US
See Chun Phan - Menlo Park CA, US
Xian Zhou - Foster City CA, US
See Chun Phan - Menlo Park CA, US
Xian Zhou - Foster City CA, US
Assignee:
GENENTECH, INC. - South San Francisco CA
International Classification:
A61K 39/395
A61K 31/7068
A61K 45/06
A61K 31/7068
A61K 45/06
Abstract:
This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human subjects susceptible to or diagnosed with breast cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
Possible Relatives
NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.